THE BIG IDEA
I have vague memories of the Electrolux vacuum salesman coming to our house to sell his wares. Over the last 40 or so years, the basic idea of enticing people to take advantage of a “deal” hasn’t changed much. But the and... Read More

There remains a lot of news-driven action and crosscurrents, but when looking at the major indexes, the market’s had its second straight constructive week. As we write this, both the S&P 500 and Nasdaq are looking at 1.8%-ish gains in the holiday-shortened week. Read More

As summer morphs into fall and Wall Street returns to full operation, I’m seeing some welcome signs of buying in the cannabis sector. So today we’ll join them, by averaging up in two of our holdings.
Read More

The economy is still solid and the market isn’t overpriced in this low interest rate world. The S&P 500 is only 2% higher than it was in January of 2018, 20 months ago. The stock market is still the best place to be. spikes... Read More

Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction. Read More

A New Format for Cabot Undervalued Stocks Advisor
Cabot Undervalued Stocks Advisor is taking on a new format. I enjoyed writing about the pertinent news on affected companies in recent weeks, without updating minor news and numbers for the rest of the portfolio companies. going... Read More

Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to... Read More

Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to... Read More

Latest Videos

Upcoming Events

• How to Make Money in the Age of US-China Rivalry + 3 Global Stocks to Buy NowFREE Webinar with Carl Delfeld, Chief Analyst of Cabot Global Stocks Explorer
Wednesday, October 23 at 2:00 PM ET |Learn More

Reviews

"Mike, I bought your 10 Low-Priced Stocks Report, and purchased 1,000 shares of AMCC at 7.95 per share, and 1,000 shares of DCIX at 5.75 per share. I sold DCIX @ 6.62 and 6.68, so I made approximately $900 on the trade. I'm still holding AMCC because of the background information you gave us about them. I don't know how you guys do it—with the profit I've made, I invested some of it in your Cabot Small-Cap Confidential newsletter and Cabot Top Ten Trader. So I've made a great profit, got two of your newsletters, and still have a lot left over with more profits to come from AMCC, and all from investing $25 for your list of January effect stocks. I'm beginning to think that the closest thing to investing in a "sure thing" is to follow Cabot's advice. I don't know who is smarter: you, for your recommendations, or me for following them, haha! Anyway, I'm a lifetime subscriber!!!! Thank you for giving me the confidence to invest."

-M. Trimas, Farmington Hills, Michigan

Market Update

From Cabot Top Ten Trader

To say it’s been a topsy-turvy week has been an understatement. The rotation that we started to pick up on a couple of weeks ago was unleashed late last Friday and the first couple of days of this week, with just about any stock and sector that’s enjoyed a good run this year coming under pressure—including more than a few names that flashed abnormal intermediate-term action. Right now is basically the definition of an environment where you should take things on a stock-by-stock basis. If your loss limits are tripped, sell. If a decent winner you had is back to breakeven, put in a tight stop. And if you have a good-sized winner that’s tripped its stop, sell at least some of your shares, if not all.